Drug Manufacturers - General

The Drug Manufacturers - General industry has a total of 19 stocks, with a combined market cap of $3,096.11 billion, total revenue of $676.65 billion and a weighted average PE ratio of 33.96.

Market Cap

3,096.11B

Revenue

676.65B

Profits

91.16B

PE Ratio

33.96

Profit Margin

13.47%

Dividend Yield

2.31%

19 Stocks

No.	Symbol	Company Name	Market Cap	% Change	Volume	Revenue
1	LLY	Eli Lilly and Company	691.32B	1.35%	9,442,468	40.86B
2	NVO	Novo Nordisk A/S	363.97B	-17.83%	53,361,361	40.47B
3	JNJ	Johnson & Johnson	347.83B	0.62%	7,767,944	87.70B
4	ABBV	AbbVie Inc.	310.27B	2.37%	17,496,344	55.53B
5	MRK	Merck & Co., Inc.	248.03B	-1.48%	10,830,057	63.17B
6	AZN	AstraZeneca PLC	199.90B	1.41%	9,010,238	51.21B
7	NVS	Novartis AG	193.93B	0.35%	1,223,715	49.94B
8	PFE	Pfizer Inc.	149.38B	2.29%	45,988,021	59.38B
9	AMGN	Amgen Inc.	141.58B	0.84%	13,367,837	32.53B
10	SNY	Sanofi	119.20B	0.44%	2,373,375	54.03B
11	BMY	Bristol-Myers Squibb Company	116.28B	1.83%	45,046,908	47.44B
12	GILD	Gilead Sciences, Inc.	115.37B	1.62%	22,359,312	28.30B
13	GSK	GSK plc	67.72B	0.51%	6,212,542	41.97B
14	BIIB	Biogen Inc.	21.34B	-0.62%	5,424,847	9.61B
15	GRFS	Grifols, S.A.	5.99B	-2.72%	1,448,800	7.81B
16	OGN	Organon & Co.	3.75B	0.97%	7,839,484	6.41B
17	AMRN	Amarin Corporation plc	189.22M	-1.18%	2,516,420	241.02M
18	SCLX	Scilex Holding Company	58.95M	1.64%	974,539	50.83M
19	MIRA	MIRA Pharmaceuticals, Inc.	17.55M	6.00%	376,291	-